Jung A, Mermillod B, Schenk R, Courvoisier B, Burkhardt P, Epiney J
Schweiz Med Wochenschr. 1976 Nov 27;106(48):1667-73.
10 patients with active symptomatic Paget's disease of bone have been treated for 6 months with disodium etidronate (EHDP) at a dose of 20 mg/kg/day. A statistically significant fall in the serum levels of alkaline phosphatase and urinary hydroxyproline was observed. However, only 2 patients experienced a significant reduction of bone pain. 6 patients were partially improved and 2 patients showed no change. Iliac crest biopsies after treatment demonstrated dimunution of the abnormal structure of the pagetic bone, but also a considerable increase in unmineralized osteoid borders. The future potentialities for treatment of Paget's disease are discussed.
10例有症状的活动性骨佩吉特病患者接受了依替膦酸二钠(EHDP)治疗,剂量为20mg/kg/天,为期6个月。观察到血清碱性磷酸酶水平和尿羟脯氨酸水平有统计学意义的下降。然而,只有2例患者的骨痛明显减轻。6例患者部分改善,2例患者无变化。治疗后的髂嵴活检显示,佩吉特病骨的异常结构减少,但未矿化的类骨质边缘也有相当程度的增加。本文讨论了治疗佩吉特病的未来潜力。